ROC curve analysis to assess the performance of CCL18 in identifying patients with PF-ILD showed an area under the curve (AUC) of 0.843 (95% CI 0.74–0.95, p < 0.001) (Figure 2B). This evidence concerns the gene CCL18 and interstitial lung disease.